Clover Announces Positive Phase 2/3 Results in Adolescents

29
DVAX: Clover Biopharmaceuticals
2022-08-25 06:23:27 Clover Announces Positive Phase 2/3 Results in Adolescents for its COVID-19 Vaccine

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.